Literature DB >> 2027992

Cystic fibrosis: scoring system with thin-section CT.

M Bhalla1, N Turcios, V Aponte, M Jenkins, B S Leitman, D I McCauley, D P Naidich.   

Abstract

The progression of lung disease in patients with cystic fibrosis (CF) was evaluated with chest radiography. The severity and extent of the various radiographic changes were scored with the Chrispin or the Birmingham method, which involves the use of imprecise and subjective terms, such as line shadows, large pulmonary shadows, and nodular cystic lesions. Although computed tomography (CT) has been shown to be helpful in the evaluation of lung disease in CF, no scoring system or other objective criteria have been developed for the evaluation of the wide range of pulmonary changes in these patients. A CT scoring system was devised that incorporates all of the changes seen in the lungs of patients with CF. Such a scoring system may facilitate objective evaluation of existing and newly developed therapeutic regimens and may be a valuable tool in the preoperative evaluation of patients being considered for lobectomy or bullectomy and in the selection of patients for lung transplantation.

Entities:  

Mesh:

Year:  1991        PMID: 2027992     DOI: 10.1148/radiology.179.3.2027992

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  131 in total

1.  Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis.

Authors:  Pieter C Goeminne; Patrick Verschueren; Hans Scheers; Lieven J Dupont
Journal:  Clin Rheumatol       Date:  2011-09-22       Impact factor: 2.980

2.  Persistent sputum cellularity and neutrophils may predict bronchiectasis.

Authors:  Nicole Drost; Liesel D'silva; Ryan Rebello; Ann Efthimiadis; Frederick E Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

3.  Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry.

Authors:  Edwin J R van Beek; Catherine Hill; Neil Woodhouse; Stanislao Fichele; Sally Fleming; Bridget Howe; Sandra Bott; Jim M Wild; Christopher J Taylor
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

4.  Proton MRI appearance of cystic fibrosis: comparison to CT.

Authors:  Michael Puderbach; Monika Eichinger; Julie Gahr; Sebastian Ley; Siegfried Tuengerthal; Astrid Schmähl; Christian Fink; Christian Plathow; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

5.  Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.

Authors:  Casilda Olveira; Alicia Padilla; Antonio Dorado; Victoria Contreras; Eduardo Garcia-Fuentes; Elehazara Rubio-Martin; Nuria Porras; Esperanza Doña; Ana Carmona; Gabriel Olveira
Journal:  Eurasian J Med       Date:  2017-06

Review 6.  Assessment of lung function in children by cross-sectional imaging: techniques and clinical applications.

Authors:  Michael Puderbach; Hans-Ulrich Kauczor
Journal:  Pediatr Radiol       Date:  2005-11-15

7.  New Zealand national incidence of bronchiectasis "too high" for a developed country.

Authors:  J Twiss; R Metcalfe; E Edwards; C Byrnes
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

8.  Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?

Authors:  S C Langton Hewer
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

Review 9.  [MRI in mucoviscidosis (cystic fibrosis)].

Authors:  M Eichinger; M Puderbach; C-P Heussel; H-U Kauczor
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

10.  High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible?

Authors:  Anastasia Oikonomou; John Tsanakas; Elpis Hatziagorou; Fotios Kirvassilis; Stavros Efremidis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2007-11-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.